| 1 |
Schnitzler L, Evers SMAA, Jackson LJ, Paulus ATG, Roberts TE. Are intersectoral costs considered in economic evaluations of interventions relating to sexually transmitted infections (STIs)? A systematic review. BMC Public Health 2022;22:2180. [PMID: 36434561 DOI: 10.1186/s12889-022-14484-z] [Reference Citation Analysis]
|
| 2 |
Chahal D, Lee JG, Yoshida EM, Lowe C, Ho F, Sum V, Kwan P. Seroprevalence of hepatitis B in previously undiagnosed patients: A community screening study. CanLivJ. [DOI: 10.3138/canlivj-2021-0008] [Reference Citation Analysis]
|
| 3 |
Xu X, Wu C, Jiang L, Peng C, Pan L, Zhang X, Shen W, Chen L, Lou Z, Xu K, Li L, Dong Y, Ruan B. Cost-Effectiveness of Hepatitis B Mass Screening and Management in High-Prevalent Rural China: A Model Study From 2020 to 2049. Int J Health Policy Manag 2021;11:2115-23. [PMID: 34664496 DOI: 10.34172/ijhpm.2021.126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 4 |
Kim JU, Ingiliz P, Shimakawa Y, Lemoine M. Improving care of migrants is key for viral hepatitis elimination in Europe. Bull World Health Organ 2021;99:280-6. [PMID: 33953445 DOI: 10.2471/BLT.20.260919] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 5 |
Charania NA, Gaze N, Kung JY, Brooks S. Interventions to reduce the burden of vaccine-preventable diseases among migrants and refugees worldwide: A scoping review of published literature, 2006-2018. Vaccine 2020;38:7217-25. [PMID: 33008670 DOI: 10.1016/j.vaccine.2020.09.054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 6 |
Ogunwobi OO, Dibba O, Zhu L, Ilboudo A, Tan Y, Fraser MA, Ma GX. Hepatitis B Virus Screening and Vaccination in First-generation African Immigrants: A Pilot Study. J Community Health 2019;44:1037-43. [PMID: 31123877 DOI: 10.1007/s10900-019-00668-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 7 |
Boga JA, Casado L, Fernández-Suarez J, Moran N, Rodríguez-Perez M, Martínez-Sela M, Pérez A, Garcia-Perez A, Menendez C, Santos S, Rodriguez-Guardado A. Screening Program for Imported Diseases in Immigrant Women: Analysis and Implications from a Gender-Oriented Perspective. Am J Trop Med Hyg 2020;103:480-4. [PMID: 32342844 DOI: 10.4269/ajtmh.19-0687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 8 |
Sagnelli C, Sagnelli E. Towards the worldwide eradication of hepatitis B virus infection: A combination of prophylactic and therapeutic factors. World J Clin Infect Dis 2019; 9(2): 11-22 [DOI: 10.5495/wjcid.v9.i2.11] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 9 |
Martin NK, Vickerman P, Khakoo S, Ghosh A, Ramsay M, Hickman M, Williams J, Miners A. Chronic hepatitis B virus case-finding in UK populations born abroad in intermediate or high endemicity countries: an economic evaluation. BMJ Open 2019;9:e030183. [PMID: 31256040 DOI: 10.1136/bmjopen-2019-030183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 10 |
Greenaway C, Castelli F. Migration Medicine. Infect Dis Clin North Am 2019;33:265-87. [PMID: 30712766 DOI: 10.1016/j.idc.2018.10.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 11 |
Chahal HS, Peters MG, Harris AM, McCabe D, Volberding P, Kahn JG. Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States. Open Forum Infect Dis 2019;6:ofy353. [PMID: 30931346 DOI: 10.1093/ofid/ofy353] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 12 |
Leidner AJ, Murthy N, Chesson HW, Biggerstaff M, Stoecker C, Harris AM, Acosta A, Dooling K, Bridges CB. Cost-effectiveness of adult vaccinations: A systematic review. Vaccine 2019;37:226-34. [PMID: 30527660 DOI: 10.1016/j.vaccine.2018.11.056] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 13 |
Suijkerbuijk AWM, van Hoek AJ, Koopsen J, de Man RA, Mangen MJ, de Melker HE, Polder JJ, de Wit GA, Veldhuijzen IK. Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country. PLoS One 2018;13:e0207037. [PMID: 30408079 DOI: 10.1371/journal.pone.0207037] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 14 |
Gétaz L, Casillas A, Siegrist CA, Chappuis F, Togni G, Tran NT, Baggio S, Negro F, Gaspoz JM, Wolff H. Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland's largest pre-trial prison. J Glob Health 2018;8:020407. [PMID: 30140433 DOI: 10.7189/jogh-08-020407] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 15 |
Myran DT, Morton R, Biggs BA, Veldhuijzen I, Castelli F, Tran A, Staub LP, Agbata E, Rahman P, Pareek M, Noori T, Pottie K. The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review. Int J Environ Res Public Health 2018;15:E1898. [PMID: 30200406 DOI: 10.3390/ijerph15091898] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 16 |
Binka M, Butt ZA, Wong S, Chong M, Buxton JA, Chapinal N, Yu A, Alvarez M, Darvishian M, Wong J, McGowan G, Torban M, Gilbert M, Tyndall M, Krajden M, Janjua NZ. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada. World J Gastroenterol 2018; 24(11): 1216-1227 [PMID: 29568202 DOI: 10.3748/wjg.v24.i11.1216] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 17 |
Pfeil J, Hufnagel M. Rational Diagnostics and Therapies in Child Refugees. Pediatr Infect Dis J 2018;37:272-4. [PMID: 29135825 DOI: 10.1097/INF.0000000000001823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 18 |
Akhtar F, Rehman S. A Public Health Analysis on Gaps in Disease Monitoring and Opportunities for Improved Care for the Management of Hepatitis B and C. Cureus 2018;10:e2077. [PMID: 29560290 DOI: 10.7759/cureus.2077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 19 |
Ahmad AA, Falla AM, Duffell E, Noori T, Bechini A, Reintjes R, Veldhuijzen IK. Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries. BMC Infect Dis 2018;18:34. [PMID: 29325525 DOI: 10.1186/s12879-017-2921-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 20 |
Mitchell T, Lee D, Weinberg M, Phares C, James N, Amornpaisarnloet K, Aumpipat L, Cooley G, Davies A, Tin Shwe VD, Gajdadziev V, Gorbacheva O, Khwan-Niam C, Klosovsky A, Madilokkowit W, Martin D, Htun Myint NZ, Yen Nguyen TN, Nutman TB, O'Connell EM, Ortega L, Prayadsab S, Srimanee C, Supakunatom W, Vesessmith V, Stauffer WM. Impact of Enhanced Health Interventions for United States-Bound Refugees: Evaluating Best Practices in Migration Health. Am J Trop Med Hyg 2018;98:920-8. [PMID: 29260657 DOI: 10.4269/ajtmh.17-0725] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 21 |
Nayagam S, Sicuri E, Lemoine M, Easterbrook P, Conteh L, Hallett TB, Thursz M. Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries. BMC Infect Dis 2017;17:692. [PMID: 29143675 DOI: 10.1186/s12879-017-2778-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 22 |
Jablonka A, Solbach P, Wöbse M, Manns MP, Schmidt RE, Wedemeyer H, Cornberg M, Behrens GMN, Hardtke S. Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015. Eur J Gastroenterol Hepatol 2017;29:939-45. [PMID: 28492419 DOI: 10.1097/MEG.0000000000000889] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 23 |
Walters J, Sullivan A. Early Identification and Linkage to Care of Foreign-Born People with Chronic Hepatitis B Virus Infection, Multnomah County, Oregon, 2012-2014. Public Health Rep 2016;131 Suppl 2:105-11. [PMID: 27168669 DOI: 10.1177/00333549161310S216] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 24 |
Hvass AMF, Wejse C. Systematic health screening of refugees after resettlement in recipient countries: a scoping review. Ann Hum Biol 2017;44:475-83. [PMID: 28562071 DOI: 10.1080/03014460.2017.1330897] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 25 |
Rafferty ERS, Gagnon HL, Farag M, Waldner CL. Economic evaluations of vaccines in Canada: a scoping review. Cost Eff Resour Alloc 2017;15:7. [PMID: 28484344 DOI: 10.1186/s12962-017-0069-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 26 |
Mangen MJ, Stibbe H, Urbanus A, Siedenburg EC, Waldhober Q, de Wit GA, van Steenbergen JE; National Working Group of hepatitis B behavioural risk-groups vaccination program. Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile. Vaccine 2017;35:3215-21. [PMID: 28483198 DOI: 10.1016/j.vaccine.2017.04.068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 27 |
Smith B, Isaacs D. Infectious Diseases in Refugee Children: To Screen or Not to Screen. Curr Pediatr Rep 2016;4:84-89. [DOI: 10.1007/s40124-016-0103-6] [Reference Citation Analysis]
|
| 28 |
Stawinska-Witoszynska B, Zysnarska M, Krzywinska-Wiewiorowska M, Wojtyła-Buciorab P, Krzyzaniak A, Wieckowska B. Trends in the Incidence Rates of Chronic Hepatitis B in Poland in the Years 2005 - 2013. Hepat Mon 2016;16:e32692. [PMID: 27799960 DOI: 10.5812/hepatmon.32692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 29 |
Geue C, Wu O, Xin Y, Heggie R, Hutchinson S, Martin NK, Fenwick E, Goldberg D; Consortium., ECDC. Cost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling Techniques. PLoS One 2015;10:e0145022. [PMID: 26689908 DOI: 10.1371/journal.pone.0145022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 30 |
Napoli C, Dente MG, Kärki T, Riccardo F, Rossi P, Declich S; Network for the Control of Cross-Border Health Threats in the Mediterranean Basin and Black Sea. Screening for Infectious Diseases among Newly Arrived Migrants: Experiences and Practices in Non-EU Countries of the Mediterranean Basin and Black Sea. Int J Environ Res Public Health 2015;12:15550-8. [PMID: 26670237 DOI: 10.3390/ijerph121215002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 31 |
Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, Dokmeci AK, Gane E, Hou JL, Jafri W, Jia J, Kim JH, Lai CL, Lee HC, Lim SG, Liu CJ, Locarnini S, Al Mahtab M, Mohamed R, Omata M, Park J, Piratvisuth T, Sharma BC, Sollano J, Wang FS, Wei L, Yuen MF, Zheng SS, Kao JH. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1-98. [PMID: 26563120 DOI: 10.1007/s12072-015-9675-4] [Cited by in Crossref: 1348] [Cited by in F6Publishing: 1457] [Article Influence: 168.5] [Reference Citation Analysis]
|
| 32 |
Osiowy C, Giles E, Trubnikov M, Choudhri Y, Andonov A. Characterization of Acute and Chronic Hepatitis B Virus Genotypes in Canada. PLoS One. 2015;10:e0136074. [PMID: 26406309 DOI: 10.1371/journal.pone.0136074] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 33 |
Custer B, Janssen MP; for the Alliance of Blood Operators Risk-Based Decision-Making (RBDM) Initiative. Health economics and outcomes methods in risk-based decision-making for blood safety: HEALTH ECONOMIC METHODS FOR BLOOD SAFETY. Transfusion 2015;55:2039-47. [DOI: 10.1111/trf.13080] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 34 |
Petersen E. Should we offer screening for hepatitis B and other infections to immigrants--legal or illegal? J Travel Med 2015;22:73-5. [PMID: 25753020 DOI: 10.1111/jtm.12188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 35 |
Jazwa A, Coleman MS, Gazmararian J, Wingate LT, Maskery B, Mitchell T, Weinberg M. Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential? Vaccine 2015;33:1393-9. [PMID: 25595868 DOI: 10.1016/j.vaccine.2015.01.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 36 |
Kärki T, Napoli C, Riccardo F, Fabiani M, Dente MG, Carballo M, Noori T, Declich S. Screening for infectious diseases among newly arrived migrants in EU/EEA countries--varying practices but consensus on the utility of screening. Int J Environ Res Public Health 2014;11:11004-14. [PMID: 25337945 DOI: 10.3390/ijerph111011004] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
|
